Troxerutin-ACOS, 300 mg capsules 100 pcs

Pharmacotherapeutic group: venotonic and venoprotective agent

ATC code: C05СА04.

Pharmacological properties.

Indications

The drug Troxerutin capsules 300 mg is used in the complex therapy of the above diseases:

– chronic venous insufficiency;

– trophic disorders in chronic venous insufficiency and trophic ulcers;

– varicose veins;

– superficial thrombophlebitis, periphlebitis;

– postthrombotic syndrome;

– Post-traumatic edema and soft tissue hematomas;

– as adjunctive treatment after sclerotherapy and/or removal of varicose

/p>

dilated veins of the lower extremities;

– hemorrhoids (to relieve symptoms);

– diabetic angiopathy, retinopathy.

Active ingredient

Composition

In 1 capsule:

The active substance: troxerutin – 300 mg.

Excipients: calcium stearate, talc, povidone (grade 90), sodium carboxymethyl starch (sodium starch glycolate (type A), primogel), microcrystalline M 102 cellulose.

The composition of gelatin capsule № 0: iron oxide yellow dye, titanium dioxide, gelatin.

How to take, the dosage

Ingestion. Capsules should be swallowed whole with meals, drinking enough water.

In the initial phase of treatment, 1 capsule (300 mg) 3 times a day is prescribed. The effect usually develops within 2 weeks. Further treatment is continued in the same dose, or it is reduced to an average therapeutic dose – 1 capsule 2 times a day (600 mg), or it is suspended (in which case the effect is maintained for at least 4 weeks). If necessary, the dose can be increased after consultation with the doctor. The course of treatment averages 3-4 weeks.

For maintenance therapy it is enough to take 1 capsule (300 mg) per day for 3-4 weeks.

In case of diabetic retinopathy troxerutin is indicated in 2 capsules (single dose of 600 mg) 3 times daily (daily dose 1.8 g).

The average duration of the therapeutic course is 3 to 4 weeks.

The need for longer treatment is determined after consultation with a physician and on an individual basis.

Interaction

Concomitant use increases the effect of ascorbic acid on the resistance and permeability of the vascular wall.

Special Instructions

Troxerutin has not been used in children under 18 years of age.

In the treatment of superficial thrombophlebitis or deep vein thrombosis, the use of the drug does not exclude the need for anti-inflammatory and antithrombotic therapy.

Troxerutin is ineffective in edema due to concomitant liver, kidney and heart disease.

The maximum periods and recommended doses should not be exceeded when using the drug alone.

If symptoms do not decrease or get worse while using the drug, you should see a physician immediately.

Influence on driving, operating machinery

The use of the drug Troxerutin has no effect on motor and mental reactions and does not prevent driving vehicles and other complex mechanisms.

Synopsis

Contraindications

– hypersensitivity to troxerutin and other components of the drug;

– gastric ulcer, duodenal ulcer, chronic gastritis in the phase

acute conditions;

– pregnancy (1st trimester);

– breastfeeding period;

– children under 18 years of age (experience of use is limited).

With caution

In patients with chronic renal insufficiency (with long-term use).

Side effects

Troxerutin is very well tolerated, in rare cases there are mild adverse reactions.

Immune system disorders: hypersensitivity reactions.

Nervous system disorders: headache.

vascular disorders: blood rushes to the face.

Gastrointestinal tract disorders: nausea, vomiting, stomach pain, flatulence, diarrhea, erosive-ulcerative lesions of the gastrointestinal tract.

Skin and subcutaneous tissue disorders: erythema, skin itching, skin rash.

If any of the side effects listed in the instructions worsen, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose

In case of overdose, consult a doctor immediately.

Troxerutin has very low toxicity. Overdose may cause the following symptoms: agitation, nausea, headache, “rushes” of blood to the face.

Treatment: it is necessary to flush the stomach, take activated charcoal (within an hour after intake), consult a doctor, symptomatic and supportive treatment is carried out if necessary.

Pregnancy use

The use of Troxerutin during the first trimester of pregnancy is contraindicated. The possibility of using the drug in the second and third trimesters of pregnancy is determined by the physician and is possible only if the expected benefits to the mother exceed the potential risk to the fetus.

If it is necessary to use the drug in the second and third trimesters of pregnancy, a physician should be consulted.

There are no data on the penetration of Troxerutin into breast milk. The use of the drug Troxerutin during breast-feeding is contraindicated.

Similarities